Patients with opioid use disorder are frequently hospitalized with complications from the condition, yet don’t receive treatment for their underlying disease. This is a missed opportunity that leaves patients at high risk of future overdose. These hospitalizations are an ideal opportunity to start effective medication treatment for addiction and connect patients to ongoing outpatient services.

Two key treatments for opioid use disorder — buprenorphine and methadone — have been proven to cut overdose rates by two-thirds, lower HIV infections, and reduce criminal behavior. As many as 70% of patients are still in treatment after one year, compared to 6% of patients receiving medication-free treatment. However, when patients being treated with buprenorphine or methadone are hospitalized, these medications are often discontinued, increasing their risk of relapse.

This program — Support for Hospital Opioid Use Treatment (Project SHOUT) — provides clinical leaders with the tools they need to start and maintain patients on buprenorphine or methadone during hospitalizations for any condition, be it medical, surgical, or obstetric. Specialists from the University of California, San Francisco (UCSF) provide a suite of supports: coaching, toolkits, protocols, monographs for pharmacy and therapeutics committees, webinars, and onsite presentations.

Additional resources are available in a public Google Drive folder. For more information or to join the coalition, please register here.

Hannah Snyder, MD
SHOUT Project Lead
Clinical Fellow, Primary Care Addiction Medicine
Division of HIV, ID, and Global Medicine & Dept. of Family and Community Medicine
UCSF at Zuckerberg San Francisco General

Diana Coffa, MD
SHOUT Project Mentor
Associate Professor
Director, Family and Community Medicine Residency Program
UCSF at Zuckerberg San Francisco General

Sarah Windels
SHOUT Project Manager
Independent Consultant